Biblio

Export 624 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
Journal Article
Y. Yamada, Shinkawa, K., Kobayashi, M., Caggiano, V., Nemoto, M., Nemoto, K., and Arai, T., Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment., J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
I. Terao and Kodama, W., Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
J. A. Matías-Guiu, Cabrera-Martín, M. Nieves, Curiel, R. E., Valles-Salgado, M., Rognoni, T., Moreno-Ramos, T., Carreras, J. Luis, Loewenstein, D. A., and Matías-Guiu, J., Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
N. Altomari, Bruno, F., Laganà, V., Smirne, N., Colao, R., Curcio, S., Di Lorenzo, R., Frangipane, F., Maletta, R., Puccio, G., and Bruni, A. Cecilia, A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 691-699, 2022.
S. Wong, Bertoux, M., Savage, G., Hodges, J. R., Piguet, O., and Hornberger, M., Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 51, no. 3, pp. 889-903, 2016.
P. N. Tariot, Braeckman, R., and Oh, C., Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil., J Alzheimers Dis, vol. 90, no. 1, pp. 161-172, 2022.
E. Racine, Forlini, C., Aspler, J., and Chandler, J., Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses., J Alzheimers Dis, vol. 51, no. 1, pp. 1-9, 2016.
A. Medoro, Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Di Marco, R., Intrieri, M., Raimo, G., and Russo, C., Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer., J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
N. Puentes-Díaz, Chaparro, D., Reyes-Marquez, V., Morales-Morales, D., Flores-Gaspar, A., and Alí-Torres, J., Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease., J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
X. Sun, Ma, R., Yao, X., Shang, X., Wang, Q., Wang, J. - Z., and Liu, G., Concanavalin agglutinin levels are decreased in peripheral blood of Alzheimer's disease patients., J Alzheimers Dis, vol. 49, no. 1, pp. 63-72, 2016.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S., Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms., J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
A. Mahzarnia, Lutz, M. W., and Badea, A., A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5., J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
M. Pievani, Pini, L., Ferrari, C., Pizzini, F. B., Galazzo, I. Boscolo, Cobelli, C., Cotelli, M., Manenti, R., and Frisoni, G. B., Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Networks., J Alzheimers Dis, vol. 57, no. 3, pp. 825-843, 2017.
H. - L. Sun, Zhou, F. - Y., Chen, D. - W., Tan, C. - R., Zeng, G. - H., Liu, Y. - H., Wang, J., Le Bu, X. -, Wang, Y. - J., Li, H. - Y., and Jin, W. - S., The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 3, pp. 1321-1328, 2022.
R. R. Romano, Carter, M. A., Dietrich, M. S., Cowan, R. L., Bruehl, S. P., and Monroe, T. B., Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals., J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up., J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
M. Golzari-Sorkheh, Weaver, D. F., and Reed, M. A., COVID-19 as a Risk Factor for Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 1, pp. 1-23, 2023.
N. Vaishnav, Gonzalez, R., Karunungan, K., Tyler, A., Zheng, W., and Arias, J. J., Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease., J Alzheimers Dis, vol. 98, no. 1, pp. 187-195, 2024.
L. GjØra, Strand, B. Heine, Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., and Selbæk, G., Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study., J Alzheimers Dis, vol. 79, no. 3, pp. 1213-1226, 2021.
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease., J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
J. A. Matías-Guiu, Pytel, V., and Matías-Guiu, J., Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia., J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
D. W. Scharre, Weichart, E., Nielson, D., Zhang, J., Agrawal, P., Sederberg, P. B., Knopp, M. V., and Rezai, A. R., Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 621-633, 2018.
H. Y. H. Hui, Ran, A. Ran, Dai, J. Jia, and Cheung, C. Y., Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives., J Alzheimers Dis, vol. 94, no. 1, pp. 39-50, 2023.
G. D'Onofrio, Panza, F., Sancarlo, D., Paris, F. F., Cascavilla, L., Mangiacotti, A., Lauriola, M., Paroni, G. H., Seripa, D., and Greco, A., Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach., J Alzheimers Dis, vol. 51, no. 2, pp. 427-37, 2016.

Pages